AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Nanobiotix S.A. American Depositary Shares
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00Y9D2TR2
29.36▲ 0.17 (0.58%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
29.19
Day's Range
28.36 – 29.54
52-Week Range
14.78 – 57.14
Volume
69.4K
Avg Volume
143.1K
Share Statistics
Shares Outstanding
Employees
97
Exchange
XNAS
Listed
2020-12-11
Share count as of December 31, 2025

Nanobiotix S.A. American Depositary Shares (NBTX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Nanobiotix S.A. American Depositary Shares (NBTX)
What is Nanobiotix S.A. American Depositary Shares's Market Cap?
Nanobiotix S.A. American Depositary Shares's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's Enterprise Value?
Nanobiotix S.A. American Depositary Shares's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's Price / Sales?
Nanobiotix S.A. American Depositary Shares's Price / Sales is 107.4×, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's EV / Revenue?
Nanobiotix S.A. American Depositary Shares's EV / Revenue is 97.8×, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's EV / EBITDA?
Nanobiotix S.A. American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's Revenue (TTM)?
Nanobiotix S.A. American Depositary Shares's Revenue (TTM) is $13.2M, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's Net Income (TTM)?
Nanobiotix S.A. American Depositary Shares's Net Income (TTM) is -$4.6M, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's EBITDA?
Nanobiotix S.A. American Depositary Shares's EBITDA is -$32.3M, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's Diluted EPS (TTM)?
Nanobiotix S.A. American Depositary Shares's Diluted EPS (TTM) is -0.10, based on as-reported figures from SEC (XBRL) filings.
What is Nanobiotix S.A. American Depositary Shares's EBITDA Margin?
Nanobiotix S.A. American Depositary Shares's EBITDA Margin is -243.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NBTXAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of EUR, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Revenues and other income
Revenues
Other income
Total revenues and other income
Research and development expenses
Selling, general and administrative expenses
Other operating income and expenses
Total operating expenses
Operating income (loss)
Financial income
Financial expenses
Financial income (loss)
Income tax
Net loss for the period